GPAM Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of GPAM monoclonal antibodies for researching glycerol-3-phosphate acyltransferase, an essential enzyme in lipid metabolism. GPAM monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glycerol-3-phosphate acyltransferase plays a critical role in the synthesis of triglycerides and phospholipids, making it vital for cellular energy storage and membrane formation. Dysregulation of GPAM has been implicated in metabolic disorders, highlighting its significance in both basic and applied research. GPAM monoclonal antibodies enable researchers to investigate lipid metabolism pathways and their impact on cellular function. Understanding GPAM activity provides crucial insights into metabolic regulation and potential therapeutic targets. Investigating GPAM expression patterns helps reveal its role in various physiological and pathological conditions. Research with GPAM monoclonal antibodies from Santa Cruz Biotechnology advances scientific understanding of lipid metabolism and its implications for human health.